Sections
| Title | Starting Page | Number of Pages |
|---|
| Table of Contents | 2 | 3 |
| List of Tables | 3 | 1 |
| List of Figures | 4 | 1 |
| Report Guidance | 5 | 1 |
| Clinical Trials by Region | 6 | 8 |
| Clinical Trials and Average Enrollment by Country | 7 | 2 |
| Top Five Countries Contributing to Clinical Trials in Asia-Pacific | 9 | 1 |
| Top Five Countries Contributing to Clinical Trials in Europe | 10 | 1 |
| Top Countries Contributing to Clinical Trials in North America | 11 | 1 |
| Top Five Countries Contributing to Clinical Trials in Middle East and Africa | 12 | 1 |
| Top Five Countries Contributing to Clinical Trials in Central and South America | 13 | 1 |
| Clinical Trials by G7 Countries: Proportion of Glioblastoma Multiforme (GBM) to Oncology Clinical Trials | 14 | 1 |
| Clinical Trials by Phase in G7 Countries | 15 | 1 |
| Clinical Trials in G7 Countries by Trial Status | 16 | 1 |
| Clinical Trials by E7 Countries: Proportion of Glioblastoma Multiforme (GBM) to Oncology Clinical Trials | 17 | 1 |
| Clinical Trials by Phase in E7 Countries | 18 | 1 |
| Clinical Trials in E7 Countries by Trial Status | 19 | 1 |
| Clinical Trials by Phase | 20 | 2 |
| In Progress Trials by Phase | 21 | 1 |
| Clinical Trials by Trial Status | 22 | 1 |
| Clinical Trials by End Point Status | 23 | 1 |
| Subjects Recruited Over a Period of Time | 24 | 1 |
| Clinical Trials by Sponsor Type | 25 | 1 |
| Prominent Sponsors | 26 | 2 |
| Top Companies Participating in Glioblastoma Multiforme (GBM) Therapeutics Clinical Trials | 27 | 1 |
| Prominent Drugs | 28 | 1 |
| Latest Clinical Trials News on Glioblastoma Multiforme (GBM) | 29 | 6 |
| Aug 04, 2016: DNAtrix Awarded FDA Orphan Products Development Grant for DNX-2401 | 29 | 1 |
| Jul 25, 2016: ImmunoCellular Therapeutics Provides Update on Lead Cancer Immunotherapy ICT-107 | 29 | 1 |
| Jul 15, 2016: ZIOPHARM Issues Statement Regarding Phase I Study of Gene Therapy Candidate Ad-RTS-hIL-12 in Brain Cancer | 30 | 1 |
| Jul 12, 2016: VAXIMM initiates Phase 1 translational study in glioblastoma with oral T-cell immunotherapy, VXM01 | 30 | 1 |
| Jun 28, 2016: New Data Suggests Improved Tumor Response For The Combination of AZIXA and Immune Checkpoint Inhibitors in The Treatment of Cancer | 31 | 1 |
| Jun 07, 2016: ImmunoCellular Therapeutics Treats First Patient in ICT-107 Phase 3 Registrational Trial in Newly Diagnosed Glioblastoma | 31 | 1 |
| Jun 06, 2016: CytRx Presents Updated Aldoxorubicin Clinical Trial Results at the 2016 American Society of Clinical Oncology Annual Meeting | 32 | 1 |
| Jun 06, 2016: TRACON Pharmaceuticals Announces Positive Results from TRC105 Clinical Trials at American Society of Clinical Oncology (ASCO) 2016 Annual Meeting | 33 | 1 |
| Jun 02, 2016: ImmunoBody vaccine to be developed for the treatment of glioblastoma multiforme | 34 | 1 |
| Clinical Trial Profile Snapshots | 35 | 865 |
| Appendix | 900 | 3 |
| Abbreviations | 900 | 1 |
| Definitions | 900 | 1 |
| Research Methodology | 901 | 1 |
| Secondary Research | 901 | 1 |
| About GlobalData | 902 | 1 |
| Contact Us | 902 | 1 |
| Disclaimer | 902 | 1 |
| Source | 903 | 1 |